HORMONE RECEPTOR POSITIVE BREAST ADENOCARCINOMA
Clinical trials for HORMONE RECEPTOR POSITIVE BREAST ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HORMONE RECEPTOR POSITIVE BREAST ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for HORMONE RECEPTOR POSITIVE BREAST ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise in shrinking breast tumors before surgery
Disease control CompletedThis early-phase study tested two drugs, abemaciclib and niraparib, given together before surgery in 8 people with hormone receptor-positive, HER2-negative breast cancer. The goal was to find the best dose and see if the combination could shrink tumors safely. The study focused o…
Matched conditions: HORMONE RECEPTOR POSITIVE BREAST ADENOCARCINOMA
Phase: PHASE1 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Radioactive tracer could spot hidden breast cancer tumors
Diagnosis CompletedThis early-phase trial is testing a new radioactive imaging agent called 68Ga-R10602 in 36 people with hormone receptor-positive breast cancer that has come back or spread. The agent is designed to light up tumors on PET/CT scans. The main goals are to check safety and see how we…
Matched conditions: HORMONE RECEPTOR POSITIVE BREAST ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Radionetics Oncology • Aim: Diagnosis
Last updated Jul 08, 2026 00:00 UTC